Hormone therapy for breast cancer might reduce a woman’s later risk of dementia and Alzheimer’s disease, a new study finds. Overall, hormone therapy is associated with a 7% lower risk of developing Alzheimer’s or a related dementia later in life, according to findings published July 16 in the journal JAMA Network Open. However, this link…  read on >  read on >

Early exposure to antibiotics might increase a kid’s risk of asthma by altering their gut bacteria, a new mouse study finds. Antibiotics could specifically lower gut production of indole propionic acid (IPA), a biochemical that’s crucial to long-term protection against asthma, researchers reported July 15 in the journal Immunity. “We have discovered that a consequence…  read on >  read on >

An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers report. A biochemical called nicotinamide adenine dinucleotide (NAD) tends to be lower in people with glaucoma compared to those without the eye disease, researchers found. What’s more, glaucoma patients with lower NAD levels than…  read on >  read on >

Over-the-counter nasal sprays could be a potent weapon against a major public health threat — antibiotic resistance, researchers report. Their analysis, which looked at data from nearly 14,000 adults, found that common nasal sprays could help keep upper respiratory tract infections at bay, reducing the need for antibiotics. Antibiotic resistance caused by overuse and misuse…  read on >  read on >

Some diabetes drugs appear to lower the risk that people with type 2 diabetes will develop dementia or Alzheimer’s disease, a new evidence review says. The risk of dementia and Alzheimer’s is significantly lower in patients treated with metformin or a class of meds called “sodium glucose co-transporter-2 (SGLT-2) inhibitors”, compared with other diabetes drugs,…  read on >  read on >